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Abstract
Background: Transgenic proteins expressed by genetically modified food crops are evaluated for
their potential allergenic properties prior to marketing, among others by identification of short
identical amino acid sequences that occur both in the transgenic protein and allergenic proteins. A
strategy is proposed, in which the positive outcomes of the sequence comparison with a minimal
length of six amino acids are further screened for the presence of potential linear IgE-epitopes. This
double track approach involves the use of literature data on IgE-epitopes and an antigenicity
prediction algorithm.
Results: Thirty-three transgenic proteins have been screened for identities of at least six
contiguous amino acids shared with allergenic proteins. Twenty-two transgenic proteins showed
positive results of six- or seven-contiguous amino acids length. Only a limited number of identical
stretches shared by transgenic proteins (papaya ringspot virus coat protein, acetolactate synthase
GH50, and glyphosate oxidoreductase) and allergenic proteins could be identified as (part of)
potential linear epitopes.
Conclusion: Many transgenic proteins have identical stretches of six or seven amino acids in
common with allergenic proteins. Most identical stretches are likely to be false positives. As shown
in this study, identical stretches can be further screened for relevance by comparison with linear
IgE-binding epitopes described in literature. In the absence of literature data on epitopes,
antigenicity prediction by computer aids to select potential antibody binding sites that will need
verification of IgE binding by sera binding tests. Finally, the positive outcomes of this approach
warrant further clinical testing for potential allergenicity.
Background
Commercial cultivation of genetically modified (GM)
crops has increased substantially since their market intro-
duction in the mid-1990's [1]. Most of these crops have
been modified with the agronomically important traits,
such as herbicide tolerance and insect resistance. Other
crops that are still in development and currently field test-
ed may reach the market soon. The transgenic traits that
these future crops carry will likely be much more diverse
than at present. The safety of new proteins expressed in
these crops will be part of the safety assessment that GM
crops undergo prior to their market approval by national
governments.
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ically modified organism, such as a GM crop, is its poten-
tial allergenicity. Genetic modification can affect the
allergenicity of the modified organism in two ways: I) by
introducing allergens, or II) by changing the level or na-
ture of intrinsic allergens. Allergens can potentially be in-
troduced by the expression of transgenic proteins, because
proteins have been found to be the causative agents of
food allergies, contact allergies, and inhalant allergies
(pollen, fungal spores). Assessment of the potential aller-
genicity of a newly expressed protein usually follows the
consensus decision-tree approach of the joint Internation-
al Life Sciences Institute – International Food Biotechnol-
ogy Council (ILSI / IFBC) [2]. The path that will be
followed through this decision tree will depend on data
and outcomes, such as the allergenicity of the source of
the foreign gene, the comparison of the amino acid se-
quence of the foreign protein to the sequences of known
allergens using computer databases, and the stability of
the foreign protein to digestive enzymes (most food aller-
gens are stable to digestion). In some cases, further testing
with allergy patients' sera, followed by skin prick tests and
food challenges may be recommended.
The assessment approach, including this decision tree, is
currently discussed within the Codex alimentarius com-
mittee of the joint Food and Agriculture Organisation and
World Health Organisation (FAO/WHO) in preparation
of Codex guidelines [3]. Recent FAO/WHO Expert Con-
sultations in Rome, January 2001, and Vancouver, Sep-
tember 2001, were convened in the frame of these
discussions [4,5]. Adoption of the guidelines is expected
in the year 2003, and their implementation by Codex
Member States will follow suit. In addition, two recent ar-
ticles review the assessment methodology of potential al-
lergenicity of transgenic proteins [6,7].
It can be anticipated that many of the source organisms
that provide candidate proteins for genetic engineering
will lack a history of allergenicity. An example is a soil bac-
terium providing an enzyme that degrades herbicides and,
if expressed in crops, would convey herbicide tolerance to
these crops. In this case, the first step in the ILSI / IFBC de-
cision tree would be to compare the primary protein struc-
ture (i.e. the sequence of amino acid residues) of the novel
protein with the primary structures of known allergens. To
this end, computer algorithms are used that enable the
computer user to align a given protein sequence with the
sequences of allergenic proteins stored in a database. Two
common algorithms that can be used for these searches
are FASTA and BLAST. FASTA compares two sequences
and aligns them with each other from the amino-terminus
towards the carboxy-terminus, eventually slided with re-
spect to each other, i.e. it compares overall similarity.
BLAST on the other hand, does not focus on the overall
alignment and therefore can also identify isolated stretch-
es of similarity between two sequences in random order.
With the appropriate settings, including the use of an
"identity matrix" instead of an "evolutionary matrix",
FASTA can also be employed to search for short identical
sequences [8]. Publicly accessible Internet websites cur-
rently feature the possibility for website visitors to run
FASTA and BLAST searches (Table 1). These Internet facil-
ities may provide for an accessible tool to screen protein
sequences for identities with allergenic proteins.
Identical stretches are selected from the results of the
alignment if their size is immunologically relevant, for ex-
ample eight or more contiguous amino acids in the ILSI /
IFBC decision tree approach [2]. Shorter stretches can also
be relevant according to recent insights, because, for ex-
ample, small sequences of four and six amino acids length
can be recognised and bound by IgE antibodies from an-
tisera of allergic patients (IgE is the immunoglobulin class
associated with allergy) [9]. These stretches represent
"continuous" epitopes, i.e. antibody-binding sites consist-
ing of linear amino acid sequences. In addition, it can be
envisaged that single or a few mismatches within a stretch
of sufficient length may not affect, or even enhance, im-
munoglobulin binding. This is not discussed at present
within the Codex and would also require additional guid-
ance on the acceptability of substitutions of identical ami-
no acids. In the absence of such guidance, some false
negatives may be generated.
Continuous (linear) epitopes can be distinguished from
"discontinuous" (conformational) epitopes consisting of
amino acid residues that occur separated from each other
within the primary, one-dimensional protein sequence,
but that are within each other's proximity and accessible
for antibodies on the surface of the folded, three-dimen-
sional allergenic protein. It may be worth noting that also
structural overall similarity with an allergenic protein, i.e.
35% identity within an 80-amino acid long stretch, is be-
ing considered to become part of the assessment of poten-
tial allergenicity by Codex alimentarius. Furthermore,
Hileman et al. [10] concludes that at least 50% overall
structural identity would be a good predictor for potential
allergenicity, based on 35+% identities that these authors
found between random maize proteins and allergenic
proteins. A prediction method to pinpoint the amino acid
residues that are present within such structural, discontin-
uous epitopes was recently described [11]. For these pre-
dictions, the three-dimensional structure of the specific
protein must be either known or predictable from similar-
ity to a known protein structure. At present, this require-
ment cannot be fulfilled for most of the allergenic- and
transgenic-proteins. In addition to linear- and conforma-
tional-peptide epitopes, glycans have also been shown to
be major IgE binding sites in allergenic glycoproteins [12].Page 2 of 11
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within transgenic proteins, discussions within the FAO/
WHO currently focus on whether the minimal degree of
identity should be eight contiguous amino acids, as de-
vised by the ILSI / IFBC decision tree, or six contiguous
amino acids.
To our knowledge, no foreign protein expressed in com-
mercial genetically modified crops shares identical
stretches of eight or more amino acids with allergenic pro-
teins. If six amino acids would, however, be established as
the minimum requirement, the chance for identification
of identical stretches in transgenic proteins and allergens
will likely increase. Many of such positive outcomes will
represent "false positives" that do not constitute binding
sites (epitopes) for the allergy-associated IgE immu-
noglobulins. It can be argued, for example, that some se-
quences, based on their location on the protein surface
and on the side chain characteristics of the amino acids,
are more likely to be bound than other sequences in the
same protein. A high number of false positives will make
it impractical to use sequence alignment for assessment of
the potential allergenicity of a transgenic protein. There-
fore, further steps should enable the risk assessor to select
those similarities that constitute more likely an allergenic
hazard than others. This need for selection is further un-
derscored by the recent results reported by Hileman et al.
[10], who observed that a number of native maize pro-
teins displayed identical stretches of eight or more contig-
uous amino acids that were also present in allergenic
proteins, while transgenic Bacillus thuringiensis proteins
displayed stretches of at most seven amino acids. We
therefore propose a strategy, in which the sequence align-
ment is extended with further steps to identify the identi-
cal stretches that may contain IgE-epitopes (Figure 1). This
strategy is a two-track approach:
• In the first track, sequences of linear epitopes are extract-
ed from literature on a particular allergenic protein and
compared to the identical stretches that this protein has in
common with a transgenic protein.
• In the other track, the most antigenic site of the protein
is predicted by using a computer algorithm for antigenic-
ity prediction. Subsequently, it is verified whether this an-
tigenic site coincides with the sequence that the transgenic
protein and allergenic protein have in common. This may
provide additional information especially in case no liter-
ature data are available on the epitopes within an aller-
genic protein. Positive outcomes need further verification
by IgE-binding assays because antigenic sites are not nec-
essarily allergenic (e.g., IgE) epitopes, as can be inferred,
for example, from the fact that IgG- and IgE-immunoglob-
ulins may have different target sites on the same protein.
Transgenic proteins that probably contain epitopes, based
on the outcomes of the two tracks, should be further test-
ed clinically to determine the true potential for IgE bind-
ing by the transgenic protein and, eventually, skin prick
tests and food challenges (Figure 1).
Algorithms are available to predict the antigenicity, i.e. the
antibody binding, of peptide sequences (reviewed by
[13]). Such algorithms are used in, for example, the design
of peptide vaccines. One commonly employed algorithm
is that of Hopp and Woods [14], in which the antigenicity
of a point in the protein sequence is determined by aver-
aging the antigenicity values of this point and the amino
acids flanking this point. Hydrophilic and acidic amino
acids, for example, have high antigenicity values. The win-
dow size used for the calculation, i.e. the total number of
residues that are averaged, can be varied. Hopp and
Woods [14] concluded that a window size of six amino ac-
ids would be most reliable. In many cases, however, a
window size of seven amino acids is used, probably be-
cause the outcome can be assigned to the middle (fourth)
amino acid within this window. The point with the high-
est score can be predicted with high probability to be part
of an antigenic determinant of the protein. The Hopp and
Woods method is accessible through Internet (Table 2).
Other antigenicity prediction methods have also been de-
veloped. Some of these calculate the hydrophilicity / hy-
drophobicity of peptide stretches, like the Hopp and
Woods algorithm, whereas others take the predicted sec-
Table 1: Examples of protein sequence databases
Name Internet address Entries
EMBL http://srs.embl-heidelberg.de:8000/srs5/ EMBL, GenBank, PIR, SwissProt, and others
Entrez http://www.ncbi.nlm.nih.gov/entrez/query.fcgi GenBank, PDB, PIR, PRF, RefSeq, SwissProt, 
and others
PIR-NREF http://pir.georgetown.edu/ GenPept, PDB, PIR-PSD, RefSeq, SwissProt, 
and TrEMBL
SwissProt http://www.expasy.ch EMBL and SwissProtPage 3 of 11
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Proposed strategy for identifying potential linear IgE-epitopes in transgenic proteins
Table 2: Internet sites that offer free access to antigenicity prediction algorithms
Host Internet address Methods
Colorado State University http://arbl.cvmbs.colostate.edu/molkit/hydropa-
thy/index.html
Hopp & Woods, Kyte & Doolittle
Expasy http://us.expasy.org/cgi-bin/protscale.pl Hopp & Woods, Kyte & Doolittle, and others
Weizman Institute http://bioinformatics.weizmann.ac.il/hydroph/ Hopp & Woods, Kyte & Doolittle
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BMC Structural Biology 2002, 2 http://www.biomedcentral.com/1472-6807/2/8ondary structure (helix, sheet, turns) and protein segment
mobility into account. Combinations of such algorithms
are also used, as described, for example, by Jameson and
Wolf [15]. As an example of prediction with the aid of
combined algorithms, the antigenicity of peptides derived
from potato virus Y coat protein has been found to corre-
late well with beta turns, hydrophilicity, and protein seg-
ment mobility [16].
Van Regenmortel and Pellequer [17] tested 22 algorithms
and found that they all scored within the 50–60 % range
of correct epitope predictions. It should be noted that
these and other authors have used the algorithms to as-
sign multiple epitopes within a protein, whereas Hopp and
Woods [14] recommended to predict one epitope, i.e. the
one containing the highest scoring point of the antigenic-
ity plot. This point can be part of either a linear or a con-
formational epitope [18].
Antigenicity prediction algorithms have been successfully
employed to predict IgE epitopes in allergenic proteins.
IgE epitopes were correctly predicted with the Hopp and
Woods algorithm, for example, in the housedust mite al-
lergen Der p 2 (window size 7) [19] and in the cow's milk
allergens β-lactoglobulin and α-lactalbumin [20].
A single IgE-epitope, however, does not make a protein an
allergen. Binding of an allergenic protein containing mul-
tiple IgE epitopes to IgE on the surface of mast cells will
lead to cross-linking of these IgE molecules. This cluster-
ing of IgE molecules on the cell surface will trigger the
mast cell to release mediators, such as histamine and cy-
tokines, which cause the symptoms of allergic reactions
("anaphylaxis"). Peptides and proteins containing only
one IgE-epitope, however, will neither crosslink IgE nor
provoke an allergic reaction, and are used as antagonists
in therapy of allergic disease [21].
So far, antigenicity prediction has not been used for the
safety assessment of transgenic proteins prior to market-
ing. Such a prediction may prove helpful if a transgenic
protein shares with allergenic proteins identical stretches
for which it is unknown if they are part of an epitope.
In the present work, it has been investigated if foreign pro-
teins expressed in market-approved transgenic crops share
identical peptides of at least six contiguous amino acids
with known allergens. It has been verified whether these
identical stretches constitute linear IgE binding epitopes
by searching literature on allergenic epitopes. In addition,
the antigenicity of the identical stretches has been predict-
ed by the Hopp and Woods method.
Results
Sequence similarities with allergens
The procedure and results of this investigation are sum-
marised in Figures 2 and 3, respectively. For detailed re-
sults, see additional file 1. Two-thirds of the thirty-three
aligned transgenic proteins displayed identical stretches
of at least six contiguous amino acids with allergenic pro-
teins. The size of the identical peptides shared by trans-
genic proteins and allergenic proteins was in 75 out of 83
cases six amino acids, and seven amino acids in the re-
maining eight cases (Figure 3). Not all of the allergenic
proteins appear on the official list of allergens composed
by the Allergen Nomenclature Subcommittee of the joint
World Health Organisation and International Union of
Immunological Societies (WHO / IUIS; Table 3). This is in
some cases due to the recent discovery of a particular aller-
genic protein that has not been listed yet.
Antigenicity prediction by computer
Table 4 features the identical stretches between a transgen-
ic- and an allergenic-protein that were predicted by the
Hopp and Woods method to be antigenic in either one. It
should be noted that, particularly, positive predictions of
antigenicity for sequences in allergenic proteins warrant
further investigation. The window size of six amino acids
has been recommended for this method. The additional
positive outcomes using a window size of seven amino ac-
ids are also shown, which indicate the effect of changing
the window size.
Discussion
A comparison was made between the molecular structures
of 33 transgenic proteins and those of allergenic proteins
by alignment of their amino acid sequences obtained
from public protein databanks. This comparison yielded
83 identical stretches of at least six contiguous amino ac-
ids length in 22 transgenic proteins. These results confirm
previous reports by Gendel [8] and Hileman et al. [10] in
which identical stretches of at most seven amino acids be-
tween a limited number of transgenic proteins and aller-
genic proteins were found. For many of these stretches, it
remains unknown if they are true epitopes that bind IgE
antibodies from sera of patients allergic to the specific al-
lergen.
Table 5 lists four identical stretches that are assumed rele-
vant based on at least one of the following criteria:
• Predicted antigenicity within the allergenic protein indi-
cating potential binding of the stretch by IgE from allergic
patients.
• Binding of IgE to peptides containing the identical
stretch as reported by literature.Page 5 of 11
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Procedure followed in this investigation
Figure 3
Outcome of the sequence alignment of transgenic proteins to allergenic proteins
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BMC Structural Biology 2002, 2 http://www.biomedcentral.com/1472-6807/2/8• Sharing of two or more stretches of identity by a trans-
genic protein with an allergenic protein. In the "worst
case" scenario, these stretches are true IgE-epitopes and
can therefore bind at least two IgE molecules on the sur-
face of mast cells in allergic individuals. Such "cross-link-
ing" of IgE is known to trigger the release of histamine and
cytokines from the mast cells, leading to anaphylaxis.
Cry1Ac, for example, shares two identical peptides,
GNAAPQ and GSTGITI with cedar pollen allergens. Hopp
and Wood's prediction method does not indicate, howev-
er, pronounced antigenicity for the GNAAPQ sequence in
the cedar pollen allergens and yields a negative score for
the GSTGITI sequence. It therefore appears that no further
testing would be needed. In contrast, the peptide EKQKEK
shared by Papaya Ringspot Virus coat protein with nema-
tode allergens can be classified as probably antigenic
based on the same prediction method (Figure 4). For the
EKQKEK sequence, no further data have been found on
the potential IgE-binding. Confirmation of IgE binding to
peptides containing the identical stretch would therefore
be the next phase in the proposed strategy (Figure 1). Fi-
nally, literature reports describe the binding of sera from
shrimp-allergic patients to peptides containing the KV-
LENR sequence of transgenic acetolactate synthase and
the LAEEAD sequence of glyphosate oxidoreductase,
which are shared with tropomyosin allergens from vari-
ous organisms. From these literature reports, it also be-
came apparent that not all tropomyosins (e.g., Pen a 1,
Pen i 1) containing these identical sequences had been re-
trieved from the protein database during the alignment.
The fact that the KVLENR and LAEEAD sequences are part
of sequences that have been shown to react with patients'
sera warrants further clinical investigation into the poten-
tial allergenicity of the transgenic proteins (Figure 1). This
would include the screening of binding of sera from aller-
gic patients to the transgenic proteins.
In short, twenty-two transgenic proteins were found to
have identical stretches in common with allergenic pro-
teins. Merely two proteins (glyphosate oxidoreductase, ac-
etolactate synthase) of these twenty-two proteins contain
identical stretches that may be IgE binding epitopes ac-
cording to literature (Table 5). For the other twenty trans-
genic proteins, either no or negative indications for IgE
binding of the identical stretches could be found in litera-
ture, while for one of these proteins (Papaya Ringspot Vi-
rus coat protein), the calculated point of highest
antigenicity of the allergenic protein coincided with the
identical stretch. The minimum length of six amino acids
was chosen for this study following the recommendation
made by a recent FAO/WHO Expert Consultation. This
consultation recommended that transgenic proteins with
positive outcomes in the alignment procedure should be
considered likely allergenic [4]. This item is currently dis-
cussed within FAO/WHO Codex alimentarius in prepara-
tion of guidelines for the risk assessment of foods derived
through biotechnology. The results of this study indicate
that, if the recommended six-amino-acids threshold is ap-
plied, the outcomes of sequence alignments of transgenic
proteins to allergenic proteins may not be conclusive
about potential allergenicity. The six-amino-acids thresh-
old therefore reflects a precautionary approach.
Our results extend previous observations made by Hile-
man et al. [10], who investigated the sequence similarities
Table 3: Allergen Databases on the Internet
Name Webadress Allergen type Information
Agmobiol http://ambl.lsc.pku.edu.cn Food, pollen Protein databank accessions, litera-
ture references
CSL http://www.csl.gov.uk/allergen 
(free registration required)
All Protein databank accessions, 
epitopes literature references
Farrp http://www.allergenonline.com 
(free registration required)
All Protein databank accessions of 658 
allergens
NCFST http://www.iit.edu/~sgendel/fa.htm All, plus coeliac Protein databank accessions
Protall http://www.ifr.bbsrc.ac.uk/protall Plant Protein databank accessions, bio-
chemical and clinical data
SDAP http://129.109.73.75/SDAP/ All Protein databank accessions, aller-
genic protein sequences, search 
facility for identical and similar 
peptide sequences1
SwissProt http://us.expasy.org/cgi-bin/
lists?allergen.txt
All Protein databank accessions
WHO/IUIS http://www.allergen.org All Nomenclature, protein databank 
accessions
1 The SDAP database and the peptide similarity search algorithm are described by Ivanciuc et al. [24]Page 7 of 11
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BMC Structural Biology 2002, 2 http://www.biomedcentral.com/1472-6807/2/8that transgenic proteins originating from Bacillus thuring-
iensis, non-allergenic proteins, and endogenous maize
proteins shared with allergenic proteins. Hileman et al.
[10] concluded among others that a threshold size of six
amino acids will not distinguish allergenic from non-al-
lergenic proteins and recommended to set a minimum
threshold of eight amino acids in order to reduce the
number of false positives. Interestingly, the eight-amino-
acid threshold proposed by Hileman et al. [10] is consist-
ent with the recommendation made by ILSI/IFBC in 1996
in their decision tree approach, which has since then been
internationally recognised by GM food safety assessors. In
this study, we propose an alternative approach to reduce
false positives by identification of potential IgE binding
epitopes among the identical stretches identified during
the sequence alignment of transgenic proteins with aller-
genic proteins (Figure 1). This alternative approach allows
to search for identical stretches with a minimum length of
six amino acids, which is sufficient for some IgEs to bind.
In this respect it is noteworthy that the two identical
stretches LAEEAD and KVLENR, which have been identi-
fied in this study as potential IgE epitopes based on liter-
ature data (Table 5), would have been missed if the eight-
amino-acids threshold were applied. Care should there-
fore be taken not only to reduce false positives, but also to
reduce the likelihood of false negatives in further refine-
ment of methods to screen for potential IgE epitopes in
transgenic proteins.
For further refinement, additional criteria may be em-
ployed. One example of an additional criterion is the "for-
eignness", i.e. the non-similarity, of a protein of interest
compared to human proteins. The underlying theory is
that the less similar the studied protein is to human pro-
teins, the more likely it represents an allergen [22]. This
approach appears to be applicable to overall structures of
transgenic- and allergenic-proteins. However, application
of this approach to potential linear IgE epitopes in trans-
genic proteins may create false negatives, because in theo-
ry, human proteins may contain single IgE epitopes
without eliciting clinical symptoms.
Table 4: Identical sequences with positive antigenicity predictions
Sequence Transgenic protein (1) Allergen (2) Antigenic?
 (highest peak)
Part of IgE 
epitope?
 (literature)
name source name source Transgenic
 protein
Allergens
w = 6 w = 7 w = 6 w = 7
PRKGSD Acetolactate synthase II
 (mutant S4-Hra)
Tobacco 
Nicotiana 
tabacum
Amb a 1.4 Ragweed Ambrosia 
artemisiifolia
- Yes - - -
TSRRRR Coat protein Cucumber 
mosaic virus
ABA-1 Roundworms Ascaris 
lumbricoides 
and A. suum
Yes Yes - (3) - (3) No (4)
EKQKEK Coat protein Papaya ring-
spot virus P
ABA-1 Roundworms Ascaris 
lumbricoides 
and A. suum
- (5) - (5) Yes (6) Yes -
VKSEDG Enoylpyruvate shikimate
 phosphate synthase
Agrobacte-
rium CP4
Der p 7 Housedust mite Der-
matophagoides pteron-
yssinus
Yes Yes - - -
LAEEAD Glyphosate oxidoreduct-
ase
Achromo-
bacter LBAA
Pan s 1 Lobster Panulirus 
stimpsoni
- - - Yes (7) Yes (8)
(1) Accessions: ALS: gi124369, CMV CP: gi593495, PRV CP: gi593497, CP4 EPSPS: gi8469107, GOX: gi1252836 (2) Accessions: Amb a 1.4: 
gi113478, gi539050, gi166445; ABA-1 (TSRRRR): gi159653, gi477301, gi2498099, gi2735096, gi2735098, gi2735100, gi2735102, gi2735104, 
gi2735106, gi2735108, gi2735110, gi2735112, gi2970629, gi7494507; ABA-1 (EKQKEK): gi2735108, gi2735110, gi2735112, gi2735114, gi2735116, 
gi2735118, gi2970629, gi7494507; Der p 7: gi1352240, gi1045602; Pan s 1: gi14285797, gi3080761 (3) Calculation not possible because TSRRRR is 
C-terminal sequence of the ABA-1 proteins. (4) The sequence RRRR of these allergens probably does not occur in vivo in the allergen as it would be 
split off from the allergen by proteases [25] (5) Sequence EKQKEK corresponds to a plateau slightly below the highest peak(s) in the antigenicity 
plots for the papaya ringspot virus coat protein (6) Highest score was shared by two or three peaks in the antigenicity plot for each ABA-1 protein 
(w = 6) (7) Highest score was shared by five peaks in the antigenicity plot for the Pan s 1 protein (window 7 amino acids) (8) Sequence LAEEAD is 
part of a 9-mer peptide from the shrimp tropomyosin allergen Pen i 1 that is bound by sera from shrimp allergic patients [26,27]. This sequence has 
also been part of two 15-mer peptides from the shrimp allergen Pen a 1 tested for sera binding. One peptide is bound by sera from allergic individ-
uals, whereas the other peptide is not [28].Page 8 of 11
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quences with certain permissible amino acid substitu-
tions. This criterion is more flexible than the current
requirement for identicalness of peptide sequences. It has
been observed that IgE binding to peptides carrying linear
IgE epitopes of the shrimp allergen Pen a 1 was not im-
paired, and in some cases even enhanced by various spe-
cific substitutions of amino acids within these peptides
[22,23].
Conclusions
Internet-hosted facilities allow the genetic engineer to
screen transgenic proteins for the presence of linear
epitopes of allergenic proteins. These facilities include the
alignment of protein sequences by using the Protein
BLAST and prediction of the antigenicity of peptide se-
quences by the Hopp and Woods method. It should be
noted that, for transgenic proteins from host organisms
without a history of allergenicity, the search for sequence
Table 5: Identical sequences between transgenic- and allergenic proteins of special interest
Transgenic protein (1) Identical peptide Allergens (2) Remark
Insecticidal protein Cry1Ac (Bacil-
lus thuringiensis kurstaki HD-73)
GNAAPQ GSTGITI Cedar pollen allergens Cup a 1, Jun 
a 1, Jun o 1, Juniperus virginiana 1–
1, and Juniperus virginiana 1–2
Two sequences shared with same 
allergens, potential crosslinking of 
IgE if bound by both sequences
Papaya Ringspot Virus coat protein EKQKEK Nematode allergen ABA-1 (Ascaris 
suum, A. lumbricoides)
Sequence predicted to be antigenic 
determinant of allergenic protein 
(Figure 4)
Acetolactate synthase (GH50 
mutant, Arabidopsis thaliana)
KVLENR (3) Shrimp allergen Met e 1 Lobster 
allergens Hom a 1 and Pan s 1 
Crab allergen Cha f 1
KVLENR is part of 15-mer pep-
tides that are recognised by sera 
from allergic patients [28,29]
Glyphosate oxidoreductase (Achro-
mobacter LBAA)
LAEEAD Shrimp allergen Met e 1 Lobster 
allergens Hom a 1 and Pan s 1 
Crab allergen Cha f 1 Fish parasite 
allergen Ani s 3
LAEEAD is part of 9-mer peptide 
from the shrimp tropomyosin 
allergen Pen i 1 that is bound by 
sera from shrimp allergic patients 
[26,27] (4)
(1) Accessions: Cry1Ac: gi117547; PRV CP: gi593497; ALS: gi124372; GOX: gi1252836 (2) Accessions: Cup a 1: gi19069497, gi9087167, gi6562326; 
Jun a 1: gi9087152, gi4138877, gi4138879; Jun o 1: gi15139849; Juniperus virginiana major pollen allergens 1–1 and 1–2: gi8843917, gi8843921; ABA-
1: gi2735108, gi2735110, gi2735112, gi2735114, gi2735116, gi2735118, gi2970629, gi7494507; Met e 1: gi607633, gi6094504; Hom a 1: gi14285796; 
Pan s 1: gi3080761, gi14285797; Cha f 1: gi7024506, gi14285800; Ani s 3: gi14423976 (3) Sequence KVLENR immediately flanks the highest peak in 
the antigenicity plot of acetolactate synthase. This peak is located between the arginine residu (KVLEN R) and the adjacent C-terminal residue (4) 
Sequence LAEEAD is also part of two 15-mer peptides from the shrimp allergen Pen a 1 tested for sera binding. One peptide is bound by sera from 
allergic individuals, whereas the other peptide is not [28].
Figure 4
Examples of antigenicity plots created with the Hopp and Woods method, window size six amino acid A Anti-
genicity plot for one of the ABA-1 allergen proteins from the nematode Ascaris lumbicoides that share the peptide sequence 
EKQKEK (arrow) with the transgenic protein Papaya Ringspot Virus coat protein. B Antigenicity plot for the transgenic pro-
tein Papaya Ringspot Virus coat protein. The sequence EKQKEK is part of a plateau slightly below the two highest peaks 
(arrow)
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steps in the assessment of the potential allergenicity.
Based on the outcome of this search, further steps may be
required to assess the potential allergenicity. As shown by
the results of this investigation, many transgenic proteins
have six- and seven-amino acid stretches in common with
allergenic proteins. If the threshold of six contiguous ami-
no acids would be lowered to five or four amino acids, the
number of outcomes can be expected to increase substan-
tially over the present output. Many of these outcomes,
however, can be expected to be "false positives". Anti-
genicity prediction methods, such as the Hopp and
Woods method, may reduce the number of false positives.
Alternatively, the transgenic protein sequence can be
aligned directly with the sequences of known linear
epitopes of allergens such that false positives will be pre-
cluded from the outcome. For this purpose, a database
with linear epitopes would be helpful, but still needs to be
constructed. In addition, supplementary methods are
needed for the prediction of conformational epitopes and
glycan-containing epitopes. In cases where multiple po-
tential epitopes have been identified within a transgenic
protein, methods to estimate the protein's ability to cross-
link IgE molecules on mast cell surfaces would enable pre-
diction of allergic reactions due to mast cell stimulation
by the particular protein.
Methods
Transgenic protein sequences
The procedure applied for this study is summarised in Fig-
ure 2. Sequences of transgenic proteins expressed in mar-
ket-approved genetically modified crops could be
retrieved from protein databases hosted on the Internet
(Table 1). The sequence of the Potato Virus Y coat protein
has been obtained from the literature [30]. Sequences
from the Cry2Ab, Cry3Aa, and Cry3Bb proteins, which are
present in pre-commercial crops, have also been included.
Transgenic proteins that are mutants of host proteins,
such as maize EPSPS expressed in GM maize, as well as hy-
pothetical proteins that could arise from engineered anti-
sense genes have been excluded from this investigation.
For Genbank accession numbers of transgenic proteins
and data on truncations and amino acid substitutions of
certain proteins, see additional file 1.
Sequence alignment
Alignments of the transgenic sequences with sequences of
allergenic proteins were carried out with the BLAST tool to
search "short nearly exact matches" on the NCBI website
http://www.ncbi.nlm.nih.gov/BLAST/, while limiting the
aligned sequences using the limit query "allergen". It
should be noted, however, that many, but not all, aller-
gens will be retrieved by the query limit "allergen". In ad-
dition, some proteins retrieved by this query limit may
not be true allergens, such as allergen binding antibodies
or sequences that resemble those of allergens. These non-
allergenic proteins should not be further considered.
The search has not been limited to food allergens, as other
types of allergens may also be relevant. Some aeroaller-
gens, for example, are cross-reactive with food allergens
(e.g. birch pollen and apple, respectively). Moreover, next
to food consumption, inhalation is another route of expo-
sure to a genetically modified crop, such as through pol-
len and dust from crop processing.
Antigenicity prediction
Antigenicity prediction plots have been created with the
graphic interface on the Colorado State University's web-
site (Table 2) for the sequences of the transgenic protein
and the allergenic protein that share the identical peptides
according to the Hopp and Woods method, using a win-
dow size of six amino acids [14]. Additional Internet facil-
ities where this calculation can be run are listed in Table 2.
Literature search
Literature has been checked for data on IgE epitopes in al-
lergenic proteins that might coincide with the identical
peptides that were identified in the alignment. For that
purpose, PubMed, an on-line version of the medical bib-
liography Medline, has been used to explore literature ref-
erences http://www.ncbi.nlm.nih.gov/entrez/query.fcgi.
In addition, information on allergenic proteins, including
literature references, is provided by a number of on-line
databases (Table 3).
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of the Hopp and Woods antigenicity prediction method and literature 
search on linear IgE epitopes.
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